Literature DB >> 1144423

Increase in erythroid colony formation in rabbits following the administration of testosterone.

Y Moriyama, J W Fisher.   

Abstract

Changes in the numbers of erythroid colonies formed in cultures from rabbits pretreated with either testosterone or busulfan plus testosterone were studied using a methyl cellulose gel system. The mean number of erythroid colonies in bone marrows from rabbits treated with testosterone in vivo was significantly higher than that of controls. However, this increase in erythroid colonies in cultures seen following testosterone treatment was completely blocked by the concurrent administration of busulfan as seen in the rabbits treated with busulfan orally and followed by testosterone injections. Busulfan has been postulated block the formation of new erythropoietin responsive cells (ERC) from hematopoietic stem cells (CFU). Thus, these findings suggest that testosterone may act directly on CFU to enhance their differentiation into the ERC compartment causing an increase in nucleated erythroid cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1144423     DOI: 10.3181/00379727-149-38767

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  3 in total

Review 1.  [Hematopoietic stimulation for enhanced bone marrow regeneration after chemotherapy (author's transl)].

Authors:  L Labedzki; D Noack
Journal:  Klin Wochenschr       Date:  1980-03-03

2.  Effects of graded doses of testosterone on erythropoiesis in healthy young and older men.

Authors:  Andrea D Coviello; Beth Kaplan; Kishore M Lakshman; Tai Chen; Atam B Singh; Shalender Bhasin
Journal:  J Clin Endocrinol Metab       Date:  2007-12-26       Impact factor: 5.958

3.  Androgens correlate with increased erythropoiesis in women with congenital adrenal hyperplasia.

Authors:  Nayananjani Karunasena; Thang S Han; Ashwini Mallappa; Meredith Elman; Deborah P Merke; Richard J M Ross; Eleni Daniel
Journal:  Clin Endocrinol (Oxf)       Date:  2016-07-25       Impact factor: 3.478

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.